Real-world Efficacy of Direct-Acting Antiviral Therapy for HCV Infection Affecting People Who Inject

Alimohammadi A, Holeksa J, Thiam A, Truong D, Conway B. Real-world efficacy of direct-acting antiviral therapy for HCV infection affecting people who inject drugs delivered in a multidisciplinary setting. Open Forum Infectious Diseases. 2018; 5(6).

Full text:

Many clinicians and insurance providers are reluctant to embrace recent guidelines identifying people who inject drugs (PWID) as a priority population to receive hepatitis C virus (HCV) treatment. The aim of this study was to evaluate the efficacy of direct-acting antiviral (DAA) HCV therapy in a real-world population comprised predominantly of PWID.

Recent Posts

See All

We are proud to share that our President and medical director, Dr. Brian Conway, participated in a new article published in the latest issue of AIDS Care Journal. The article, Disclosure of HIV-serodi